Table of contents
Expand All Topics
Chemical- and radiation-induced hemorrhagic cystitis
Guidelines
Key sources
The following summarized guidelines for the evaluation and management of chemical- and radiation-induced hemorrhagic cystitis are prepared by our editorial team based on guidelines from the Canadian Urological Association (CUA 2019) and the Multidisciplinary Consensus Panel on Chemical- and Radiation-Induced Cystitis (CRIC-MCP 2014).
1
2
Screening and diagnosis
Differential diagnosis: as per CUA 2019 guidelines, assess patients with post-radiation hematuria to identify or exclude other pathological factors that may explain or contribute to the patient's symptoms.
B
More topics in this section
Diagnosis
Diagnostic investigations
Initial assessment: as per CRIC-MCP 2014 guidelines, elicit careful history, perform physical examination and obtain laboratory examination as the basic assessment.
E
More topics in this section
Diagnostic imaging
Diagnostic procedures
Respiratory support
Medical management
General principles
As per CRIC-MCP 2014 guidelines:
Ensure a multimodality stepwise approach for the treatment of patients with hemorrhagic cystitis.
E
Decide on choice of therapy depending on the degree of hematuria.
E
More topics in this section
Supportive therapy
Sodium pentosan polysulfate
Tranexamic acid
Other systemic agents
Management of severe hemorrhagic cystitis
Therapeutic procedures
Alum irrigation: as per CUA 2019 guidelines, consider performing bladder irrigation with alum in patients with RHC. Recognize that it is a practical, easily applied and generally well-tolerated procedure with a comparatively acute onset of action. Use special caution in patients with poor renal function.
C
More topics in this section
Intravesical hyaluronic acid
Intravesical formalin
Other intravesical agents
Clot removal
Endoscopic hemostasis
Laser therapy
Transarterial embolization